N
PYXS icon

Nuveen’s Pyxis Oncology PYXS Stock Holding History

Nuveen’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-127,304
Closed -$125K – 3379
2025
Q1 		$125K Hold
127,304
– – ﹤0.01% 3196
2024
Q4 		$199K Sell
127,304
-21,720
-15% -$62.6K ﹤0.01% 3209
2024
Q3 		$547K Hold
149,024
– – ﹤0.01% 2985
2024
Q2 		$493K Buy
+149,024
New +$627K ﹤0.01% 2997
2022
Q2 		– Sell
-16,163
Closed -$65K – 3441
2022
Q1 		$65K Hold
16,163
– – ﹤0.01% 3265
2021
Q4 		$177K Buy
+16,163
New +$185K ﹤0.01% 3248

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's PYXS Position: Q2 2025 in Review

Nuveen sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 127,304 shares — an estimated $125K sold.

Nuveen first reported a position in PYXS in Q4 2021 and held it in 6 quarters. The position peaked at $547K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Nuveen reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 127,304 Pyxis Oncology shares in Q2 2025, an estimated $125K.
  • Nuveen first reported a position in Pyxis Oncology in Q4 2021 and held it in 6 quarters.
  • Nuveen's Pyxis Oncology position peaked at $547K in Q3 2024.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.